Welcome to our dedicated page for Definitive Healthcare SEC filings (Ticker: DH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Definitive Healthcare Corp. (NASDAQ: DH) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. Definitive Healthcare is a Delaware corporation focused on healthcare commercial intelligence and healthcare market data and analytics, and its filings provide formal detail on its operations, governance and financial reporting.
Investors can review current reports on Form 8-K, which the company uses to disclose material events such as quarterly financial results, leadership changes and board updates. For example, Form 8-K filings reference earnings press releases for specific quarters and describe items like results of operations, director resignations, committee appointments and executive leadership changes.
In addition to 8-Ks, users can access Definitive Healthcare’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain audited and interim financial statements, management’s discussion and analysis, risk factors, and segment and non-GAAP metric disclosures. These documents expand on metrics highlighted in earnings releases, including Adjusted EBITDA, Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Unlevered Free Cash Flow.
Stock Titan’s platform enhances these filings with AI-generated summaries that explain key sections, highlight important changes and clarify complex accounting or non-GAAP reconciliations. Real-time updates from EDGAR help ensure that new filings, including any Form 4 insider transaction reports or proxy statements related to executive compensation and governance, appear promptly.
For users researching DH stock, this page offers a structured way to read, compare and understand Definitive Healthcare’s regulatory history, financial reporting practices and corporate actions without manually parsing every line of each SEC document.
Definitive Healthcare Corp. CEO Kevin Coop had 37,593 shares of Class A Common Stock withheld on April 1 to cover tax obligations tied to vesting RSUs. This was a tax-withholding disposition, not an open-market sale. After this event, he directly holds 5,078,872 shares.
Definitive Healthcare Corp. director and executive chairman Jason Ronald Krantz had 45,154 shares of Class A Common Stock withheld on April 1, 2026 at $1.09 per share to cover tax obligations tied to the vesting of previously reported RSUs. This was a tax-withholding disposition, not an open-market sale, and was satisfied by the issuer delivering shares for the liability.
After this event, Krantz directly held 1,213,604 shares of Class A Common Stock. He also beneficially owned an additional 450,000 shares held in trust by DH Holdings (f/k/a Jason R. Krantz 2009 Trust), of which he is the beneficiary.
Definitive Healthcare Corp. reported that on March 30, 2026, director Jeff Haywood resigned from its Board of Directors and from the Board’s Human Capital Management and Compensation Committee, effective immediately. The company stated that his resignation was not due to any disagreement regarding its operations, policies, or practices.
Following his departure, the Board size was reduced from nine members to eight members, and the Compensation Committee was reduced from three members to two members, reflecting his departure rather than adding a replacement director at this time.
Definitive Healthcare Corp. reported that Chief Executive Officer Kevin Coop had 175,524 shares of Class A common stock withheld by the company at $1.28 per share. These shares were retained by the issuer to cover Coop's tax withholding obligations tied to the vesting and settlement of previously reported restricted stock units, rather than being sold in an open-market transaction. After this tax-withholding disposition, Coop directly holds 5,116,465 shares of Definitive Healthcare common stock.
Graboske Benjamin reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp. reported that EVP and Chief Data Officer Benjamin Graboske received a grant of 631,068 restricted stock units (RSUs) of Class A Common Stock. The award was recorded at a price of $0.00 per share, reflecting stock-based compensation rather than a cash purchase.
Each RSU represents a contingent right to receive one share of Class A Common Stock. According to the disclosure, 25% of these RSUs are scheduled to vest on March 1, 2027, with additional vesting at a rate of 6.25% thereafter. Following this grant, Graboske’s directly owned Class A Common Stock, including RSUs, totaled 1,312,026.654 shares.
Paris Jonathan reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp. reported that Chief Legal Officer Jonathan Paris received a grant of 481,505 restricted stock units, each representing one share of Class A common stock. According to the award terms, 25% of these RSUs vest on March 1, 2027, with 6.25% vesting every three months over the following three years, contingent on his continued service.
Heller Casey reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp.’s Chief Financial Officer, Casey Heller, reported an equity award of 733,301 restricted stock units (RSUs) tied to the company’s Class A common stock at a stated price of $0.00 per share. Each RSU represents a contingent right to receive one share.
According to the filing, 25% of these RSUs will vest on March 1, 2027, with an additional 6.25% vesting every three months over the following three years, as long as Heller remains in service. After this grant, Heller directly holds 2,007,322 shares or RSUs linked to Class A common stock.
Coop Kevin reported acquisition or exercise transactions in this Form 4 filing.
Definitive Healthcare Corp. reported that Chief Executive Officer Kevin Coop received an equity award linked to 1,735,437 shares of Class A Common Stock in the form of restricted stock units. These RSUs vest 25% on March 1, 2027, then 6.25% every three months over the next three years, contingent on his continued service. Following this grant, Coop is reported as beneficially owning 5,291,989 shares of Class A Common Stock.
Definitive Healthcare Corp. executive chairman and 10% owner Jason Ronald Krantz reported an equity award. On February 24, 2026, he acquired 242,719 restricted stock units, each representing one share of Class A common stock, at no cost. These RSUs vest 100% on March 1, 2027, subject to his continued service. After this grant, he directly holds 1,258,758 shares. He also has indirect beneficial ownership of 450,000 shares through DH Holdings, formerly the Jason R. Krantz 2009 Trust, where he is the beneficiary.
Definitive Healthcare Corp. executive updates initial ownership report. EVP and Chief Data Officer Benjamin Graboske filed an amended Form 3 to reflect beneficial ownership of 4,045.654 shares of Class A Common Stock. A footnote explains these shares were mistakenly omitted from his original Form 3 and from two subsequent Forms 4.